Injection of bone marrow cell extract into infarcted hearts results in functional improvement comparable to intact cell therapy. - Test2 - elhamkhani - TriplyDB

Injection of bone marrow cell extract into infarcted hearts results in functional improvement comparable to intact cell therapy.

Injection of bone marrow cell extract into infarcted hearts results in functional improvement comparable to intact cell therapy.

http://www.wikidata.org/entity/Q33433387

about

The Evolution of the Stem Cell Theory for Heart Failure Immunotolerant Properties of Mesenchymal Stem Cells: Updated Review Adipose tissue-derived stem cells as a therapeutic tool for cardiovascular disease Stem-cell therapy for erectile dysfunction Quantitative analysis of protein and gene expression in salivary glands of Sjogren's-like disease NOD mice treated by bone marrow soup Donor Myocardial Infarction Impairs the Therapeutic Potential of Bone Marrow Cells by an Interleukin-1-Mediated Inflammatory Response Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie's disease.IL-15: a novel prosurvival signaling pathway in cardiomyocytes.Sca-1+ cardiosphere-derived cells are enriched for Isl1-expressing cardiac precursors and improve cardiac function after myocardial injury Cardiac Function, Perfusion, Metabolism, and Innervation following Autologous Stem Cell Therapy for Acute ST-Elevation Myocardial Infarction. A FINCELL-INSIGHT Sub-Study with PET and MRI.Fractionation of mouse bone-marrow cells limits functional efficacy in non-reperfused mouse model of acute myocardial infarction.Injection of human bone marrow and mononuclear cell extract into infarcted mouse hearts results in functional improvement.Expression of a Distinct Set of Chemokine Receptors in Adipose Tissue-Derived Stem Cells is Responsible for In Vitro Migration Toward Chemokines Appearing in the Major Pelvic Ganglion Following Cavernous Nerve Injury.Advanced Donor Age Impairs Bone Marrow Cell Therapeutic Efficacy for Cardiac Disease The aging heart and post-infarction left ventricular remodeling.Cytokine combination therapy with erythropoietin and granulocyte colony stimulating factor in a porcine model of acute myocardial infarction.Pleiotrophin gene therapy for peripheral ischemia: evaluation of full-length and truncated gene variants Paracrine effects of bone marrow soup restore organ function, regeneration, and repair in salivary glands damaged by irradiation Function of mesenchymal stem cells following loading of gold nanotracers Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy.Extracellular high mobility group box 1 plays a role in the effect of bone marrow mononuclear cell transplantation for heart failure.Clinical significance of markers of collagen metabolism in rheumatic mitral valve disease.Myocardial production and release of MCP-1 and SDF-1 following myocardial infarction: differences between mice and man.Cardiac stem cell therapy: Have we put too much hype in which cell type to use?Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition.Treatment with hESC-Derived Myocardial Precursors Improves Cardiac Function after a Myocardial Infarction.Identification of the active components in Bone Marrow Soup: a mitigator against irradiation-injury to salivary glands.Bone marrow cell extract promotes the regeneration of irradiated bone.Overexpression of Nitric Oxide Synthase Restores Circulating Angiogenic Cell Function in Patients With Coronary Artery Disease: Implications for Autologous Cell Therapy for Myocardial Infarction Injections of adipose tissue-derived stem cells and stem cell lysate improve recovery of erectile function in a rat model of cavernous nerve injury.The effects of aging on apoptosis following myocardial infarction.Stem cells: novel players in the treatment of erectile dysfunction.Cardiac repair and restoration using human embryonic stem cells.Use of stem cells in heart failure treatment: where we stand and where we are going.Treatment of pulmonary arterial hypertension with circulating angiogenic cells.Aging Impairs the Proliferative Capacity of Cardiospheres, Cardiac Progenitor Cells and Cardiac Fibroblasts: Implications for Cell Therapy.Aging is protective against pressure overload cardiomyopathy via adaptive extracellular matrix remodeling.Status of stem cells in diabetic nephropathy: predictive and preventive potentials.A molecular MRI probe to detect treatment of cardiac apoptosis in vivo.Optimal timing and frequency of bone marrow soup therapy for functional restoration of salivary glands injured by single-dose or fractionated irradiation.

P2860

Q26769042-8C7307C1-62CB-4FCF-A8CD-11A010549168 Q26770107-7C339DB8-161B-4C23-B184-45D0FF5C6392 Q26795749-B6DA48B0-C7A5-4ED0-AF1E-5CF38727C8D7 Q27012672-AAFE0510-AFB4-4311-B5DE-5712CEE0DBAC Q28539302-398A0D24-60B1-4F45-8F54-2228E57A82E6 Q29304005-22E3737E-272A-4A12-B749-3234F01F2EAB Q33642378-98A8A4F5-3765-4661-858A-56E43B8ED1C6 Q33972581-660005F7-215C-4460-8776-148E64293B50 Q34137691-D7530681-ABDF-4CCF-9795-C740707BED36 Q34169758-31ECB3BC-C3A8-4FD4-9227-1DA39414135E Q34228713-7133B213-7066-4E48-BE53-7A0EBB4B99BA Q34253381-6572FE7F-D4E8-448C-B9EB-21CB10A3CDE8 Q34286884-BF7CE5ED-DB22-4A9B-BA99-106CB563E42E Q34295979-6EEB816F-E9B0-43B8-9EF2-69114AFDFDA8 Q34542195-7326BB81-2FDC-48B7-9E92-02381112D990 Q34634667-4E63D01B-6B43-44FD-8A9A-BB1E54306152 Q34695480-16C05082-76EE-4957-8809-25D7084439C7 Q34700487-F7C11DAD-ECB1-477A-8953-5C74287A2913 Q34788253-EEBFE044-2CF4-4069-8C34-A0E87C32447B Q35013816-24A320A3-3209-403C-9AB8-38230BBD7D73 Q35034878-3145F545-C406-40AC-9F68-61501BFD7D5F Q35113410-3E4E95F1-1165-47C9-8C68-23E41095187F Q35233087-37182A73-4906-4D36-9FFB-FCB6728BCB56 Q35646545-77BDED63-E4C0-484A-A034-D4B81073E387 Q35727937-B26798D0-6D87-49F5-A6C0-506CD13C0EA8 Q35731055-89C4A05A-0E1C-477D-BC8A-E35AF0532B67 Q36242110-6FF51FF0-37AB-4BB4-920F-5EEBC5CACFDC Q36380435-941348B7-33BE-47E3-9192-06249B232735 Q36877532-4848025A-3668-4A98-9056-AD03CF640826 Q37451656-72458F9A-A806-468C-B0F8-1CA78D86D92F Q37493150-8E1D2180-D0CF-49C7-9398-AD5040B53E6B Q37946242-2DC80E33-7212-4ECD-9C92-1A8B63B64EB7 Q38041270-8713E2F9-2D15-4868-A18E-E060BB849DA0 Q38168204-8D311465-553C-4FA7-85F5-EDAE5D79251E Q39772665-7C412885-EE49-43AA-B6AD-24CC2F03EF7A Q40666319-C31329E7-7DF9-4999-B61A-BA3A8C58A1B2 Q40955749-452331E9-7A60-4825-99C7-2EB314CE3CE5 Q41296335-56A24DD1-EB66-4F55-AB76-23D4051A0C85 Q42823514-975766E8-4A20-4A27-8074-1E19B39C6E2C Q47916534-9CC22E06-2940-4A39-B909-4237AE0D16C5

P2860

Injection of bone marrow cell extract into infarcted hearts results in functional improvement comparable to intact cell therapy.

http://www.wikidata.org/entity/Q33433387

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Injection of bone marrow cell ...... arable to intact cell therapy.

@ast

Injection of bone marrow cell ...... arable to intact cell therapy.

@en

type

label

Injection of bone marrow cell ...... arable to intact cell therapy.

@ast

Injection of bone marrow cell ...... arable to intact cell therapy.

@en

prefLabel

Injection of bone marrow cell ...... arable to intact cell therapy.

@ast

Injection of bone marrow cell ...... arable to intact cell therapy.

@en

P1433

Q33433387-EAF69A23-068A-4BF5-9FEE-316D47B2F7FA

P1476

Q33433387-134B77DC-F29F-4985-A031-DB71EE2F889E

P2093

Q33433387-131777F1-AE7B-4DA3-BDAC-217CE5F018F8

Q33433387-3E0E2A5F-F302-4F04-B1F3-4EBB8988292E

Q33433387-44B64C72-C98D-425D-BA46-BD8F6337CA73

Q33433387-44C5DC06-944E-48C3-A7D7-F640F37C9A54

Q33433387-5C8FD7C4-E448-457E-A5B4-2A5277D91A02

Q33433387-5DFF3FE0-F961-40C6-AE7F-5F21737ECA4F

Q33433387-6EA10D41-1D6E-43B7-87CE-8809B81A0180

Q33433387-85D54D6D-6836-42C9-B95F-7282CAEEECE5

Q33433387-91A67B61-01B0-483A-8E96-9468022E53FB

Q33433387-AE6CACD1-9ABB-433A-B7BC-DD14ADF128C2

P2860

Q33433387-0A29450B-CBBF-4412-8A22-35C8C983518A

Q33433387-24A69E9E-7E22-42A2-A134-874F579A51D0

Q33433387-2C9A8C1D-290C-4166-A7CD-18947E18B51F

Q33433387-3943F4EA-0DF1-4A55-BCDF-7AA629D77A92

Q33433387-398560A4-2E80-46D9-8D89-3AA2BCEA768C

Q33433387-406B5054-34AF-432E-B6D4-B673D69B619C

Q33433387-46195353-6112-4D20-A777-69F2D96F0026

Q33433387-508154E2-1F33-4F1E-BAAF-28A03BB72644

Q33433387-532CE80F-267C-420A-A16C-D5FCA2C366A2

Q33433387-5A65168A-D1E1-44B2-BC5E-C6879984876D

P304

Q33433387-4F10C4F5-C67F-475B-B629-8AF1C4F41AB8

P31

Q33433387-6F664F19-82FD-4329-91D1-BDB5F11B0722

P356

Q33433387-9B77D645-9C15-4625-8B01-E187E912378B

P433

Q33433387-BE77EAE8-13DF-4F4D-8627-FF7127D657F8

P478

Q33433387-F0182AD3-3C18-4F9F-A31A-9DA79E540E12

P50

Q33433387-8A2EBAE5-71AC-45D2-B039-1C9A21A18E83

P577

Q33433387-BE1AF6EB-56BA-43D5-8866-C1F482F8F67B

P5875

Q33433387-83AE5BBB-6C6E-4B66-824C-7DC2EE0E4323

P698

Q33433387-64C666EC-B0E5-413F-933A-5A1C35F0BA02

P932

Q33433387-BC7DCC6A-F492-4D97-B49F-359439C3984C

P356

P1433

Molecular Therapy

P1476

Injection of bone marrow cell ...... arable to intact cell therapy.

@en

P2093

Franca S Angeli

http://www.w3.org/2001/XMLSchema#string

Henry Shih

http://www.w3.org/2001/XMLSchema#string

Jianqin Ye

http://www.w3.org/2001/XMLSchema#string

Juha Koskenvuo

http://www.w3.org/2001/XMLSchema#string

Junya Takagawa

http://www.w3.org/2001/XMLSchema#string

Maelene L Wong

http://www.w3.org/2001/XMLSchema#string

Matthew L Springer

http://www.w3.org/2001/XMLSchema#string

Megha Prasad

http://www.w3.org/2001/XMLSchema#string

Mohan N Viswanathan

http://www.w3.org/2001/XMLSchema#string

Neel K Kapasi

http://www.w3.org/2001/XMLSchema#string

P2860

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

Biomaterials for the Treatment of Myocardial Infarction

Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction

Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells

Bone marrow cells regenerate infarcted myocardium

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.

Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans.

Adult bone marrow-derived cells: regenerative potential, plasticity, and tissue commitment.

Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial.

Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function.

P304

1250-1256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2009.85

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24346435

http://www.w3.org/2001/XMLSchema#string

P698

19384293

http://www.w3.org/2001/XMLSchema#string

P932

2835212

http://www.w3.org/2001/XMLSchema#string